Evogene Ltd. (EVGN) income statement
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30
$0.34−0.05 (-13.17%)
Close on Nov 17, 2026Market cap $2.97MP/E 0.3Yield –
Evogene Ltd. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- -6.3%
- Operating margin
- -364.2%
- Net margin
- -220.2%
- Return on equity, FY2025
- 1107.0%
Financial strength
- Current ratio
- 3.57
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 306.0%
Valuation
- P/E ratio
- 0.3
- Price to sales
- 0.77
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?